May 29, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
FDA draft guidance aims to reduce animal testing in cancer drug development
The FDA has issued draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.Once finalized, this would reduce the time it takes for new cancer drugs to go from discovery to patient use.
413 words~2 min read
